rs35971380
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_021930.6(RINT1):āc.2003T>Cā(p.Phe668Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000553 in 1,614,146 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_021930.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RINT1 | NM_021930.6 | c.2003T>C | p.Phe668Ser | missense_variant | 13/15 | ENST00000257700.7 | NP_068749.3 | |
EFCAB10 | NM_001355526.2 | c.*54A>G | 3_prime_UTR_variant | 5/5 | ENST00000480514.6 | NP_001342455.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RINT1 | ENST00000257700.7 | c.2003T>C | p.Phe668Ser | missense_variant | 13/15 | 1 | NM_021930.6 | ENSP00000257700 | P1 | |
EFCAB10 | ENST00000480514.6 | c.*54A>G | 3_prime_UTR_variant | 5/5 | 1 | NM_001355526.2 | ENSP00000418678 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00285 AC: 434AN: 152166Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000807 AC: 203AN: 251442Hom.: 1 AF XY: 0.000559 AC XY: 76AN XY: 135892
GnomAD4 exome AF: 0.000313 AC: 458AN: 1461862Hom.: 2 Cov.: 31 AF XY: 0.000241 AC XY: 175AN XY: 727234
GnomAD4 genome AF: 0.00285 AC: 434AN: 152284Hom.: 0 Cov.: 33 AF XY: 0.00287 AC XY: 214AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 02, 2020 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
RINT1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at